Dow reports first quarter 2023 results
Dow reported a GAAP loss per share of $0.13 and operating earnings of $0.58 for Q1 2023, significantly down from $2.34 a year ago. The net sales fell 22% year-over-year to $11.9 billion, attributed to a 11% volume decrease and a 10% local price decline. Equity losses were $48 million, a stark contrast to $174 million in earnings last year. Operating EBIT was $708 million, down from $2.4 billion in Q1 2022. Cash flow from operations decreased by $1.1 billion year-over-year. Despite these challenges, the company is on track to achieve $1 billion in cost savings by year-end. Dow maintains a strong liquidity position and emphasizes ongoing efforts to enhance its cash generation capabilities.
- Achieving $1 billion in cost savings in 2023.
- Operating EBIT improved by $107 million sequentially.
- Cash flow conversion at 85% on a trailing 12-month basis.
- Net sales declined by 22% year-over-year.
- GAAP net loss of $73 million.
- Equity losses of $48 million compared to prior equity earnings.
- Operating EBIT decreased by $1.7 billion year-over-year.
FINANCIAL HIGHLIGHTS
- GAAP loss per share was
; operating earnings per share (EPS)1 was$0.13 , compared to$0.58 in the year-ago period and$2.34 in the prior quarter. Operating EPS excludes significant items in the quarter, totaling$0.46 per share, primarily due to restructuring costs and a litigation matter.$0.71 - Net sales were
, down$11.9 billion 22% versus the year-ago period, reflecting declines in all operating segments driven by slower global macroeconomic activity. Sales were flat sequentially, as gains in Performance Materials & Coatingsand Packaging & Specialty Plastics offset declines in Industrial Intermediates & Infrastructure. - Volume decreased
11% versus the year-ago period, led by a15% decline inEurope , theMiddle East ,Africa , andIndia (EMEAI). Sequentially, volume increased by2% , due to gains in Performance Materials & Coatingsand Packaging & Specialty Plastics . - Local price declined
10% versus the year-ago period and4% sequentially, with declines in all operating segments and regions due to industry supply additions amidst continued soft global economic conditions. - Currency decreased net sales by
1% year-over-year, and increased net sales by2% sequentially. - Equity losses were
, compared to equity earnings of$48 million in the year-ago period, driven by declines at the Company's principal joint ventures. Equity losses were$174 million in the prior quarter. Sequentially, the earnings decline was primarily driven by planned maintenance activity at Sadara.$43 million - GAAP net loss was
. Operating EBIT1 was$73 million , down$708 million versus the year-ago period, with declines in all operating segments due to lower local prices and reduced operating rates to match market dynamics. Sequentially, Op. EBIT was up$1.7 billion , primarily driven by Performance Materials & Coatings.$107 million - Cash provided by operating activities – continuing operations was
, down$531 million year-over-year and down$1.1 billion compared to the prior quarter. The Company delivered cash flow conversion1 of$1.5 billion 85% on a trailing 12-month basis. - Returns to shareholders totaled
in the quarter, including$621 million in dividends and$496 million in share repurchases.$125 million
SUMMARY FINANCIAL RESULTS
Three Months Ended | Three Months Ended Dec 31 | ||||
In millions, except per share amounts | 1Q23 | 1Q22 | vs. SQLY [B / (W)] | 4Q22 | vs. PQ [B / (W)] |
GAAP Income (Loss), Net of Tax | |||||
Operating EBIT¹ | |||||
Operating EBIT Margin¹ | 6.0 % | 15.9 % | (990) bps | 5.1 % | 90 bps |
Operating EBITDA¹ | |||||
GAAP Earnings (Loss) Per Share | |||||
Operating Earnings Per Share¹ | |||||
Cash Provided by Operating |
- Op. Earnings Per Share, Op. EBIT, Op. EBIT Margin, Op. EBITDA, and Cash Flow Conversion are non-GAAP measures.
See page 6 for further discussion.
CEO QUOTE
"Team Dow demonstrated its agility and remained disciplined through challenging macroeconomic conditions – leveraging our structurally advantaged feedstock positions, focusing on higher-value products where demand remained resilient, and aligning our operating rates with market dynamics. Our actions to deliver
"Additionally, the annual benchmarking we published today reflects our differentiated portfolio and our disciplined and balanced capital allocation track record. Focused on industry-leading cash generation, Dow delivered best-in-class free cash flow yield on a three-year average and net debt reduction since spin. We also achieved above-peer median three-year average EBITDA margins, return on invested capital, and returns to shareholders, supported by our investments in higher-return, faster-payback and lower-risk projects."
SEGMENT HIGHLIGHTS
Packaging & Specialty Plastics
Three Months Ended | Three Months Ended | ||||
In millions, except margin | 1Q23 | 1Q22 | vs. SQLY [B / (W)] | 4Q22 | vs. PQ [B / (W)] |
Operating EBIT | |||||
Operating EBIT Margin | 10.5 % | 16.2 % | (570) bps | 10.8 % | (30) bps |
Equity Earnings |
Packaging & Specialty Plastics segment net sales in the quarter were
Equity earnings were
Operating EBIT was
Packaging and Specialty Plastics business reported a net sales decrease versus the year-ago period, as gains in functional polymers – primarily for renewable energy applications – were more than offset by lower local polyethylene prices and lower industrial and consumer packaging sales volumes in EMEAI and
Hydrocarbons & Energy business reported a net sales decrease compared to the year-ago period, driven primarily by lower olefin and aromatic sales in EMEAI. Sequentially, net sales increased primarily due to higher olefin volumes in EMEAI and the
Industrial Intermediates & Infrastructure
Three Months Ended | Three Months Ended | ||||
In millions, except margin | 1Q23 | 1Q22 | vs. SQLY [B / (W)] | 4Q22 | vs. PQ [B / (W)] |
Operating EBIT | |||||
Operating EBIT Margin | 3.6 % | 14.6 % | (1,100) bps | 4.5 % | (90) bps |
Equity Earnings (Losses) |
Industrial Intermediates & Infrastructure segment net sales were
Equity losses for the segment were
Operating EBIT was
Polyurethanes & Construction Chemicals business reported a net sales decrease compared to the year-ago period, primarily driven by lower demand for building & construction, consumer durables, and industrial applications. Sequentially, net sales declined primarily driven by lower local price for propylene oxide and its derivatives and isocyanates.
Industrial Solutions business reported a decrease in net sales compared to the year-ago period, as resilient demand in pharmaceutical and energy end-markets was more than offset by lower demand for coatings and industrial applications. Sequentially, net sales decreased as improved demand for home care and cleaning applications was more than offset by reduced supply availability from weather-related impacts and a third-party outage, combined with lower demand in industrial end-markets.
Performance Materials & Coatings
Three Months Ended | Three Months Ended | ||||
In millions, except margin | 1Q23 | 1Q22 | vs. SQLY [B / (W)] | 4Q22 | vs. PQ [B / (W)] |
Operating EBIT | |||||
Operating EBIT Margin | 1.5 % | 19.5 % | (1,800) bps | (6.3) % | 780 bps |
Equity Earnings | - |
Performance Materials & Coatings segment net sales in the quarter were
Operating EBIT was
Consumer Solutions business reported a decrease in net sales versus the year-ago period, driven by lower local price and volumes for siloxanes that more than offset resilient demand for commercial building and construction and mobility applications. Sequentially, net sales increased as improved supply availability for siloxanes, seasonally higher demand in building & construction, and reduced value-chain destocking pressure were partly offset by lower local prices for siloxanes.
Coatings & Performance Monomers business reported a decrease in net sales compared to the year-ago period, as improved monomer supply availability and resilient demand for industrial coatings were more than offset by lower demand for architectural coatings and local price declines. Sequentially, net sales increased as seasonally higher volumes in the
OUTLOOK
"Looking to the remainder of the year, our consistent and disciplined execution enhances our ability to navigate the impact of higher inflation on consumer demand and soft global economic activity. We expect the benefit of our operational and cost actions to continue to build as we progress through 2023. We will remain flexible, responding quickly as conditions evolve and expect oil and gas spreads to further support our strategic cost-advantaged positions," said Fitterling. "Importantly, the underlying long-term growth fundamentals in our market verticals remain intact, as we advance both our Decarbonize and Grow and Transform the Waste strategies to raise our underlying earnings profile by
Conference Call
Dow will host a live webcast of its first quarter earnings conference call with investors to discuss its results, business outlook and other matters today at
About Dow
Dow (NYSE: DOW) combines global breadth; asset integration and scale; focused innovation and materials science expertise; leading business positions; and environmental, social and governance leadership to achieve profitable growth and help deliver a sustainable future. The Company's ambition is to become the most innovative, customer centric, inclusive and sustainable materials science company in the world. Dow's portfolio of plastics, industrial intermediates, coatings and silicones businesses delivers a broad range of differentiated, science-based products and solutions for its customers in high-growth market segments, such as packaging, infrastructure, mobility and consumer applications. Dow operates manufacturing sites in 31 countries and employs approximately 37,800 people. Dow delivered sales of approximately
Cautionary Statement about Forward-Looking Statements
Certain statements in this press release are "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Such statements often address expected future business and financial performance, financial condition, and other matters, and often contain words or phrases such as "anticipate," "believe," "estimate," "expect," "intend," "may," "opportunity," "outlook," "plan," "project," "seek," "should," "strategy," "target," "will," "will be," "will continue," "will likely result," "would" and similar expressions, and variations or negatives of these words or phrases.
Forward-looking statements are based on current assumptions and expectations of future events that are subject to risks, uncertainties and other factors that are beyond Dow's control, which may cause actual results to differ materially from those projected, anticipated or implied in the forward-looking statements and speak only as of the date the statements were made. These factors include, but are not limited to: sales of Dow's products; Dow's expenses, future revenues and profitability; the continuing global and regional economic impacts of the coronavirus disease 2019 ("COVID-19") pandemic and other public health-related risks and events on Dow's business; any sanctions, export restrictions, supply chain disruptions or increased economic uncertainty related to the ongoing conflict between
Where, in any forward-looking statement, an expectation or belief as to future results or events is expressed, such expectation or belief is based on the current plans and expectations of management and expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the expectation or belief will result or be achieved or accomplished. A detailed discussion of principal risks and uncertainties which may cause actual results and events to differ materially from such forward-looking statements is included in the section titled "Risk Factors" contained in the Company's Annual Report on Form 10-K for the year ended
®TM Trademark of
Non-GAAP Financial Measures
This earnings release includes information that does not conform to GAAP and are considered non-GAAP measures. Management uses these measures internally for planning, forecasting and evaluating the performance of the Company's segments, including allocating resources. Dow's management believes that these non-GAAP measures best reflect the ongoing performance of the Company during the periods presented and provide more relevant and meaningful information to investors as they provide insight with respect to ongoing operating results of the Company and a more useful comparison of year-over-year results. These non-GAAP measures supplement the Company's GAAP disclosures and should not be viewed as alternatives to GAAP measures of performance. Furthermore, such non-GAAP measures may not be consistent with similar measures provided or used by other companies. Non-GAAP measures included in this release are defined below. Reconciliations for these non-GAAP measures to GAAP are provided in the Selected Financial Information and Non-GAAP Measures section starting on page 11. Dow does not provide forward-looking GAAP financial measures or a reconciliation of forward-looking non-GAAP financial measures to the most comparable GAAP financial measures on a forward-looking basis because the Company is unable to predict with reasonable certainty the ultimate outcome of pending litigation, unusual gains and losses, foreign currency exchange gains or losses and potential future asset impairments, as well as discrete taxable events, without unreasonable effort. These items are uncertain, depend on various factors, and could have a material impact on GAAP results for the guidance period.
Operating Earnings Per Share is defined as "Earnings (loss) per common share - diluted" excluding the after-tax impact of significant items.
Operating EBIT is defined as earnings (i.e., "Income (loss) before income taxes") before interest, excluding the impact of significant items.
Operating EBIT Margin is defined as Operating EBIT as a percentage of net sales.
Operating EBITDA is defined as earnings (i.e., "Income (loss) before income taxes") before interest, depreciation and amortization, excluding the impact of significant items.
Free Cash Flow is defined as "Cash provided by operating activities - continuing operations," less capital expenditures. Under this definition, Free Cash Flow represents the cash generated by the Company from operations after investing in its asset base. Free Cash Flow, combined with cash balances and other sources of liquidity, represent the cash available to fund obligations and provide returns to shareholders. Free Cash Flow is an integral financial measure used in the Company's financial planning process.
Cash Flow Conversion is defined as "Cash provided by operating activities - continuing operations," divided by Operating EBITDA. Management believes Cash Flow Conversion is an important financial metric as it helps the Company determine how efficiently it is converting its earnings into cash flow.
Operating Return on Capital (ROC) is defined as net operating profit after tax, excluding the impact of significant items, divided by total average capital, also referred to as ROIC.
Consolidated Statements of Income | ||
In millions, except per share amounts (Unaudited) | Three Months Ended | |
|
| |
Net sales | $ 11,851 | $ 15,264 |
Cost of sales | 10,629 | 12,402 |
Research and development expenses | 214 | 218 |
Selling, general and administrative expenses | 428 | 498 |
Amortization of intangibles | 81 | 88 |
Restructuring and asset related charges - net | 541 | 186 |
Equity in earnings (losses) of nonconsolidated affiliates | (48) | 174 |
Sundry income (expense) - net | 79 | 148 |
Interest income | 76 | 28 |
Interest expense and amortization of debt discount | 185 | 167 |
Income (loss) before income taxes | (120) | 2,055 |
Provision (credit) for income taxes | (47) | 503 |
Net income (loss) | (73) | 1,552 |
Net income (loss) attributable to noncontrolling interests | 20 | (17) |
Net income (loss) available for | $ (93) | $ 1,569 |
Per common share data: | ||
Earnings (loss) per common share - basic | $ (0.13) | $ 2.12 |
Earnings (loss) per common share - diluted | $ (0.13) | $ 2.11 |
Weighted-average common shares outstanding - basic | 708.2 | 734.6 |
Weighted-average common shares outstanding - diluted | 708.2 | 739.8 |
Consolidated Balance Sheets | ||
In millions, except share amounts (Unaudited) |
|
|
Assets | ||
Current Assets | ||
Cash and cash equivalents | $ 3,319 | $ 3,886 |
Accounts and notes receivable: | ||
Trade (net of allowance for doubtful receivables - 2023: | 5,740 | 5,611 |
Other | 2,072 | 2,144 |
Inventories | 6,825 | 6,988 |
Other current assets | 1,400 | 1,848 |
Total current assets | 19,356 | 20,477 |
Investments | ||
Investment in nonconsolidated affiliates | 1,508 | 1,589 |
Other investments (investments carried at fair value - 2023: | 2,815 | 2,793 |
Noncurrent receivables | 627 | 666 |
Total investments | 4,950 | 5,048 |
Property | ||
Property | 58,679 | 58,055 |
Less: Accumulated depreciation | 38,356 | 37,613 |
Net property | 20,323 | 20,442 |
Other Assets | ||
8,653 | 8,644 | |
Other intangible assets (net of accumulated amortization - 2023: | 2,336 | 2,442 |
Operating lease right-of-use assets | 1,257 | 1,227 |
Deferred income tax assets | 995 | 960 |
Deferred charges and other assets | 1,446 | 1,363 |
Total other assets | 14,687 | 14,636 |
Total Assets | $ 59,316 | $ 60,603 |
Liabilities and Equity | ||
Current Liabilities | ||
Notes payable | $ 278 | $ 362 |
Long-term debt due within one year | 247 | 362 |
Accounts payable: | ||
Trade | 4,575 | 4,940 |
Other | 1,985 | 2,276 |
Operating lease liabilities - current | 304 | 287 |
Income taxes payable | 335 | 334 |
Accrued and other current liabilities | 2,765 | 2,770 |
Total current liabilities | 10,489 | 11,331 |
Long-Term Debt | 14,739 | 14,698 |
Other Noncurrent Liabilities | ||
Deferred income tax liabilities | 744 | 1,110 |
Pension and other postretirement benefits - noncurrent | 3,799 | 3,808 |
Asbestos-related liabilities - noncurrent | 844 | 857 |
Operating lease liabilities - noncurrent | 1,007 | 997 |
Other noncurrent obligations | 6,979 | 6,555 |
Total other noncurrent liabilities | 13,373 | 13,327 |
Stockholders' Equity | ||
Common stock (authorized 5,000,000,000 shares of issued 2023: 775,463,877 shares; 2022: 771,678,525 shares) | 8 | 8 |
Additional paid-in capital | 8,607 | 8,540 |
Retained earnings | 22,584 | 23,180 |
Accumulated other comprehensive loss | (7,065) | (7,139) |
(3,953) | (3,871) | |
20,181 | 20,718 | |
Noncontrolling interests | 534 | 529 |
Total equity | 20,715 | 21,247 |
Total Liabilities and Equity | $ 59,316 | $ 60,603 |
Consolidated Statements of Cash Flows | ||
In millions (Unaudited) | Three Months Ended | |
|
| |
Operating Activities | ||
Net income (loss) | $ (73) | $ 1,552 |
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||
Depreciation and amortization | 648 | 752 |
Provision (credit) for deferred income tax | (418) | 253 |
Earnings of nonconsolidated affiliates less than dividends received | 102 | 374 |
Net periodic pension benefit cost (credit) | (23) | 7 |
Pension contributions | (41) | (55) |
Net gain on sales of assets, businesses and investments | (49) | (6) |
Restructuring and asset related charges - net | 541 | 186 |
Other net loss | 347 | 140 |
Changes in assets and liabilities, net of effects of acquired and divested companies: | ||
Accounts and notes receivable | (68) | (741) |
Inventories | 163 | (443) |
Accounts payable | (631) | 86 |
Other assets and liabilities, net | 33 | (493) |
Cash provided by operating activities - continuing operations | 531 | 1,612 |
Cash provided by (used for) operating activities - discontinued operations | 4 | (9) |
Cash provided by operating activities | 535 | 1,603 |
Investing Activities | ||
Capital expenditures | (440) | (315) |
Investment in gas field developments | (55) | (37) |
Purchases of previously leased assets | (2) | (2) |
Proceeds from sales of property, businesses and consolidated companies, net of cash divested | 57 | 4 |
Acquisitions of property and businesses, net of cash acquired | (23) | — |
Investments in and loans to nonconsolidated affiliates | — | (6) |
Distributions and loan repayments from nonconsolidated affiliates | 1 | — |
Proceeds from sales of ownership interests in nonconsolidated affiliates | — | 11 |
Purchases of investments | (165) | (148) |
Proceeds from sales and maturities of investments | 512 | 141 |
Other investing activities, net | (35) | (15) |
Cash used for investing activities | (150) | (367) |
Financing Activities | ||
Changes in short-term notes payable | (91) | (21) |
Payments on short-term debt greater than three months | — | (14) |
Proceeds from issuance of long-term debt | 13 | 16 |
Payments on long-term debt | (156) | (25) |
Collections on securitization programs | — | 141 |
Purchases of treasury stock | (125) | (600) |
Proceeds from issuance of stock | 55 | 35 |
Employee taxes paid for share-based payment arrangements | (41) | (35) |
Distributions to noncontrolling interests | (13) | (1) |
Dividends paid to stockholders | (496) | (513) |
Cash used for financing activities | (854) | (1,017) |
Effect of exchange rate changes on cash, cash equivalents and restricted cash | (41) | (45) |
Summary | ||
Increase (decrease) in cash, cash equivalents and restricted cash | (510) | 174 |
Cash, cash equivalents and restricted cash at beginning of period | 3,940 | 3,033 |
Cash, cash equivalents and restricted cash at end of period | $ 3,430 | $ 3,207 |
Less: Restricted cash and cash equivalents, included in "Other current assets" | 111 | 64 |
Cash and cash equivalents at end of period | $ 3,319 | $ 3,143 |
Three Months Ended | ||
In millions (Unaudited) |
|
|
Packaging & Specialty Plastics | $ 6,114 | $ 7,627 |
Industrial Intermediates & Infrastructure | 3,378 | 4,524 |
Performance Materials & Coatings | 2,276 | 3,049 |
Corporate | 83 | 64 |
Total | $ 11,851 | $ 15,264 |
$ 4,450 | $ 5,537 | |
EMEAI 1 | 4,053 | 5,512 |
2,047 | 2,753 | |
1,301 | 1,462 | |
Total | $ 11,851 | $ 15,264 |
Net Sales Variance by Segment and | Three Months Ended | ||||
Local | Currency | Volume | Total | ||
Percent change from prior year | |||||
Packaging & Specialty Plastics | (11) % | (1) % | (8) % | (20) % | |
Industrial Intermediates & Infrastructure | (6) | (2) | (17) | (25) | |
Performance Materials & Coatings | (12) | (2) | (11) | (25) | |
Total | (10) % | (1) % | (11) % | (22) % | |
Total, excluding the Hydrocarbons & Energy business | (9) % | (2) % | (11) % | (22) % | |
(11) % | — % | (9) % | (20) % | ||
EMEAI 1 | (8) | (3) | (15) | (26) | |
(11) | (3) | (12) | (26) | ||
(11) | — | — | (11) | ||
Total | (10) % | (1) % | (11) % | (22) % |
Net Sales Variance by Segment and | Three Months Ended | ||||
Local | Currency | Volume | Total | ||
Percent change from prior quarter | |||||
Packaging & Specialty Plastics | (3) % | 2 % | 2 % | 1 % | |
Industrial Intermediates & Infrastructure | (5) | 2 | (5) | (8) | |
Performance Materials & Coatings | (5) | 2 | 14 | 11 | |
Total | (4) % | 2 % | 2 % | — % | |
Total, excluding the Hydrocarbons & Energy business | (5) % | 2 % | 1 % | (2) % | |
(4) % | — % | 6 % | 2 % | ||
EMEAI 1 | (4) | 4 | 6 | 6 | |
(3) | 2 | (12) | (13) | ||
(5) | — | 2 | (3) | ||
Total | (4) % | 2 % | 2 % | — % |
Europe ,Middle East ,Africa andIndia .
Selected Financial Information and Non-GAAP Measures | ||
Operating EBIT by Segment | Three Months Ended | |
In millions (Unaudited) |
|
|
Packaging & Specialty Plastics | $ 642 | $ 1,234 |
Industrial Intermediates & Infrastructure | 123 | 661 |
Performance Materials & Coatings | 35 | 595 |
Corporate | (92) | (71) |
Total | $ 708 | $ 2,419 |
Depreciation and Amortization by Segment | Three Months Ended | |
In millions (Unaudited) |
|
|
Packaging & Specialty Plastics | $ 320 | $ 395 |
Industrial Intermediates & Infrastructure | 128 | 150 |
Performance Materials & Coatings | 196 | 200 |
Corporate | 4 | 7 |
Total | $ 648 | $ 752 |
Operating EBITDA by Segment | Three Months Ended | |
In millions (Unaudited) |
|
|
Packaging & Specialty Plastics | $ 962 | $ 1,629 |
Industrial Intermediates & Infrastructure | 251 | 811 |
Performance Materials & Coatings | 231 | 795 |
Corporate | (88) | (64) |
Total | $ 1,356 | $ 3,171 |
Equity in Earnings (Losses) of Nonconsolidated Affiliates by Segment | Three Months Ended | |
In millions (Unaudited) |
|
|
Packaging & Specialty Plastics | $ 21 | $ 110 |
Industrial Intermediates & Infrastructure | (73) | 62 |
Performance Materials & Coatings | 3 | 3 |
Corporate | 1 | (1) |
Total | $ (48) | $ 174 |
Reconciliation of "Net income (loss)" to "Operating EBIT" | Three Months Ended | |
In millions (Unaudited) |
|
|
Net income (loss) | $ (73) | $ 1,552 |
+ Provision (credit) for income taxes | (47) | 503 |
Income (loss) before income taxes | $ (120) | $ 2,055 |
- Interest income | 76 | 28 |
+ Interest expense and amortization of debt discount | 185 | 167 |
- Significant items | (719) | (225) |
Operating EBIT (non-GAAP) | $ 708 | $ 2,419 |
Selected Financial Information and Non-GAAP Measures | ||||
Significant Items Impacting Results for the Three Months Ended | ||||
In millions, except per share amounts (Unaudited) | Pretax 1 | Net | EPS 3 | Income Statement Classification |
Reported results | $ (120) | $ (93) | $ (0.13) | |
Less: Significant items | ||||
Restructuring, implementation and | (551) | (436) | (0.61) | Cost of sales ( R&D ( |
Litigation related charges, awards and | (177) | (138) | (0.19) | Cost of sales |
Indemnification and other transaction | 9 | 9 | 0.01 | Sundry income (expense) - net |
Income tax related items 7 | — | 57 | 0.08 | Provision (credit) for income taxes |
Total significant items | $ (719) | $ (508) | $ (0.71) | |
Operating results (non-GAAP) | $ 599 | $ 415 | $ 0.58 |
Significant Items Impacting Results for the Three Months Ended | ||||
In millions, except per share amounts (Unaudited) | Pretax 1 | Net | EPS 3 | Income Statement Classification |
Reported results | $ 2,055 | $ 1,569 | $ 2.11 | |
Less: Significant items | ||||
Digitalization program costs | (41) | (32) | (0.04) | Cost of sales ( R&D ( |
Restructuring, implementation costs and | (10) | (8) | (0.01) | Cost of sales ( R&D ( |
(186) | (142) | (0.19) | Restructuring and asset related charges - net | |
Indemnification and other transaction | 12 | 12 | 0.01 | Sundry income (expense) - net |
Total significant items | $ (225) | $ (170) | $ (0.23) | |
Operating results (non-GAAP) | $ 2,280 | $ 1,739 | $ 2.34 |
- "Income (loss) before income taxes."
- "Net income (loss) available for
Dow Inc. common stockholders." The income tax effect on significant items was calculated based upon the enacted tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment. - "Earnings (loss) per common share - diluted," which includes the impact of participating securities in accordance with the two-class method.
- Restructuring charges and implementation and efficiency costs associated with the Company's 2023 Restructuring Program. Also includes certain gains and losses associated with previously impaired equity investments.
- Includes a loss associated with legacy agricultural products groundwater contamination matters.
- Primarily related to charges associated with agreements entered into with DuPont and Corteva as part of the separation and distribution which, among other matters, provides for cross-indemnities and allocations of obligations and liabilities for periods prior to, at and after the completion of the separation.
- Related to deferred tax assets in a foreign jurisdiction partially offset by a remeasurement of uncertain tax positions.
- Restructuring charges, asset related charges and costs associated with implementing the Company's 2020 Restructuring Program.
Selected Financial Information and Non-GAAP Measures | ||||
Significant Items Impacting Results for the Three Months Ended | ||||
In millions, except per share amounts (Unaudited) | Pretax 1 | Net | EPS 3 | Income Statement Classification |
Reported results | $ 865 | $ 613 | $ 0.85 | |
Less: Significant items | ||||
Digitalization program costs | (76) | (64) | (0.09) | Cost of sales ( R&D ( |
Restructuring, implementation costs and | (9) | (7) | (0.01) | Cost of sales ( R&D ( |
68 | 56 | 0.08 | Restructuring and asset related charges | |
Litigation related charges, awards and | 381 | 288 | 0.40 | Sundry income (expense) - net |
Indemnification and other transaction | 7 | 7 | 0.01 | Sundry income (expense) - net |
Total significant items | $ 371 | $ 280 | $ 0.39 | |
Operating results (non-GAAP) | $ 494 | $ 333 | $ 0.46 |
- "Income before income taxes."
- "Net income available for
Dow Inc. common stockholders." The income tax effect on significant items was calculated based upon the enacted tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment. - "Earnings per common share - diluted," which includes the impact of participating securities in accordance with the two-class method.
- Restructuring charges, asset related charges and costs associated with implementing the Company's 2020 Restructuring Program.
- Partial reversal of certain asset related reserves recorded in the first quarter of 2022 related to the conflict between
Russia andUkraine . - Related to a gain associated with a legal matter with
Nova Chemicals Corporation and a gain related to an adjustment of the Dow Silicones breast implant liability. - Primarily related to charges associated with agreements entered into with DuPont and Corteva as part of the separation and distribution which, among other matters, provides for cross-indemnities and allocations of obligations and liabilities for periods prior to, at and after the completion of the separation.
Reconciliation of Free Cash Flow | Three Months Ended | |
In millions (Unaudited) |
|
|
Cash provided by operating activities - continuing operations (GAAP) | $ 531 | $ 1,612 |
Capital expenditures | (440) | (315) |
Free Cash Flow (non-GAAP) | $ 91 | $ 1,297 |
Reconciliation of Cash Flow Conversion | Three Months Ended | |||
In millions (Unaudited) |
|
|
|
|
Cash provided by operating activities - continuing operations (GAAP) | $ 1,856 | $ 1,940 | $ 2,078 | $ 531 |
Operating EBITDA (non-GAAP) | $ 3,059 | $ 1,863 | $ 1,255 | $ 1,356 |
Cash Flow Conversion (Operating EBITDA to cash flow from | 60.7 % | 104.1 % | 165.6 % | 39.2 % |
Cash Flow Conversion - trailing twelve months (non-GAAP) | 85.0 % |
For further information, please contact:
Investors: +1 989-638-5265 | Media: +1 989-638-2417 |
Twitter: https://twitter.com/DowNewsroom
Facebook: https://www.facebook.com/dow/
LinkedIn: http://www.linkedin.com/company/dow-chemical
Instagram: http://instagram.com/dow_official
View original content to download multimedia:https://www.prnewswire.com/news-releases/dow-reports-first-quarter-2023-results-301806596.html
SOURCE
FAQ
What were Dow's earnings per share for Q1 2023?
How much did Dow's net sales decrease in Q1 2023?
What are Dow's equity losses for Q1 2023?
How did Dow's operating EBIT change in Q1 2023?